SOURCE: Analysts In Media

December 03, 2007 12:13 ET

A Shift in the Pre-Clinical Paradigm

NEW YORK, NY--(Marketwire - December 3, 2007) - Future Pharmaceuticals announces latest research that impacts cancer treatment. Robert Abraham, VP of Oncology at Wyeth Research, provides powerful insight into new methods of pre-clinical cancer research and the implications it holds for the future of oncology.

To read full story visit

Contact Information

  • For more information contact:
    Hilary Dunn
    646-747-7456 EST